1-3 of 3
Elisa Calcagno
Close
Sort by
Journal Articles

Histone Acetyltransferase (HAT) Activator, YF2, Modulates the p53:BCL6 Axis and Antigen Presentation in Diffuse Large B-Cell Lymphomas

Brian Estrella, Yuxuan Liu, Edd C Ricker, Manuel A Pazos, II, Jole Fiorito, Elisa Zuccarello, Elisa Calcagno, Barry Honig, Ottavio Arancio, Jennifer E. Amengual
Journal: Blood
Blood (2021) 138 (Supplement 1): 2254.
https://doi.org/10.1182/blood-2021-151442
Published: 2021
Journal Articles

Strategy for Overcoming Crebbp and EP300 Mutations in Lymphoma: Development of First-in-Class HAT Activators

Yuxuan Liu, PhD, Jole Fiorito, PhD, Yulissa Gonzalez, Brian Estrella, PhD, Elisa Calcagno, PhD, Elisa Zuccarello, PhD, Howook Hwang, PhD, Barry Honig, PhD, Shixian Deng, PhD, Donald Landry, MD PhD, Owen A. O'Connor, MD PhD, Ottavio Arancio, PhD, Jennifer E Amengual, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4068.
https://doi.org/10.1182/blood-2019-125983
Published: 2019
Journal Articles

Development of First-in-Class Histone Acetyltransferase (HAT) Activators for Precision Targeting of Epigenetic Derangements in Lymphoma

Yuxuan Liu, PhD, Jole Fiorito, PhD, Yulissa Gonzalez, Elisa Zuccarello, PhD, Elisa Calcagno, Adolfo Mazzeo, Nebiyu Ali Abshiru, PhD, Jeannie Camarillo, PhD, Neil L Kelleher, PhD, Changhong Qiao, Renu Nandakumar, PhD, Cremers Serge, PhD PharmD, Shixian Deng, PhD, Donald Landry, MD PhD, Owen A. O'Connor, MD, PhD, Ottavio Arancio, PhD, Jennifer E Amengual, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 37.
https://doi.org/10.1182/blood-2018-99-110447
Published: 2018